Get Integrated Data for Your Specialty and Interest Aresa
Category Select :
Items 161 ~ 180 of 25816, Page 9 of 1292
161. Novel Technique May Significantly Reduce Breast Biopsies - 12/11/2018
 Radiological Society of North America
  A combination of three-compartment breast image analysis and radiomics may improve cancer diagnosis and reduce breast biopsies...
162. Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agencys biosimilars policy framework - 12/11/2018
163. FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications - 12/11/2018
164. Digital Mammography Increases Breast Cancer Detection - 12/11/2018
 Radiological Society of North America
  Digital mammography increased cancer detection by an overall rate of 14 percent in a large UK study...
165. Abbott to Present at J.P. Morgan Healthcare Conference - 12/11/2018
  ABBOTT PARK, Ill., Dec. 11, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019. Brian Yoor, executive vice president of finance and Chief Financial Officer, will present at the conference at 11 a.m. Central time.
166. Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs - 12/10/2018
167. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs - 12/10/2018
168. New Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer - 12/10/2018
 American Cancer Society
  Study compares Kadcyla (T-DM1) to Herceptin (Trastuzumab)
169. Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data - 12/10/2018
170. Mercks President of Global Human Health Adam H. Schechter to Leave Merck Frank Clyburn Named Chief Commercial Officer and Michael Nally Named Chief Marketing Officer - 12/10/2018
171. Medtronic Named One of America''s Best Corporate Citizens in 2018 by Forbes Magazine - 12/10/2018
  DUBLIN - December 10, 2018 -?Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America''s Most JUST Companies in 2018, according to?Forbes?magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st?on this year''s JUST 100: America''s Best Corporate Citizens list for outperforming its peers in areas such as fair treatment of employees, job creation, customer treatment, and product quality.
172. American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Care - 12/10/2018
 American Academy of Ophthalmology
  Nations eye physicians and surgeons support executive branchs emphasis on patient safety as state lawmakers weigh scope-of-practice expansion
173. Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019 - 12/07/2018
  DUBLIN - December 7, 2018 -?The board of directors of?Medtronic?plc?(NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 41 consecutive years. The dividend is payable on January 18, 2019, to shareholders of record at the close of business on December 28, 2018.
174. Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDAs new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products - 12/06/2018
  One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled.
175. Statement from FDA Commissioner Scott Gottlieb, M.D., on FDAs new strategic framework to advance use of real-world evidence to support development of drugs and biologics - 12/06/2018
176. FDA Approves First Biosimilar for Non-Hodgkin Lymphoma - 12/06/2018
 American Cancer Society
  The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma.
177. Decline Stalls: 58 Million Americans Still Exposed to Secondhand Smoke - 12/06/2018
 Centers for Disease Control and Prevention
  Exposure remains high for certain groups, including kids
178. AAOS Encouraged by Administrations Plan to Promote Healthcare Competition - 12/06/2018
 American Academy of Orthopaedic Surgeons
179. Health benefits far outweigh the costs of meeting climate change goals - 12/05/2018
180. FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care - 12/04/2018
<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9[10]  >  >>

Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email :